Detalhe da pesquisa
1.
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.
Ann Oncol
; 33(10): 1052-1060, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764271